Advertisement

Topics

Reality vs. hype: A macro look at the microbiome market

18:24 EDT 8 Aug 2017 | MedCity News

Companies that target the microbiome for various therapies have rallied $840 million since 2010, according to a new report by Silicon Valley Bank that analyzes the wider progress of the field.

Original Article: Reality vs. hype: A macro look at the microbiome market

NEXT ARTICLE

More From BioPortfolio on "Reality vs. hype: A macro look at the microbiome market"

Quick Search
Advertisement